Signature Estate & Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.26M | Sell |
6,232
-418
| -6% | -$143K | 0.04% | 159 |
|
|
2026
Q1 | $2.34M | Buy |
6,650
+290
| +5% | +$103K | 0.05% | 155 |
|
|
2025
Q4 | $2.08M | Buy |
6,360
+100
| +2% | +$31.7K | 0.04% | 161 |
|
|
2025
Q3 | $1.77M | Buy |
6,260
+44
| +0.7% | +$12.8K | 0.04% | 177 |
|
|
2025
Q2 | $1.74M | Buy |
6,216
+640
| +11% | +$181K | 0.04% | 167 |
|
|
2025
Q1 | $1.74M | Buy |
5,576
+1,872
| +51% | +$553K | 0.05% | 154 |
|
|
2024
Q4 | $965K | Buy |
3,704
+17
| +0.5% | +$5.04K | 0.02% | 225 |
|
|
2024
Q3 | $1.19M | Buy |
3,687
+42
| +1% | +$13.7K | 0.03% | 178 |
|
|
2024
Q2 | $1.14M | Buy |
3,645
+878
| +32% | +$258K | 0.03% | 177 |
|
|
2024
Q1 | $787K | Sell |
2,767
-221
| -7% | -$64.7K | 0.02% | 101 |
|
|
2023
Q4 | $860K | Buy |
2,988
+226
| +8% | +$61.6K | 0.03% | 106 |
|
|
2023
Q3 | $743K | Hold |
2,762
| – | – | 0.03% | 102 |
|
|
2023
Q2 | $613K | Buy |
2,762
+28
| +1% | +$6.5K | 0.02% | 108 |
|
|
2023
Q1 | $661K | Hold |
2,734
| – | – | 0.02% | 107 |
|
|
2022
Q4 | $718K | Sell |
2,734
-5
| -0.2% | -$1.34K | 0.03% | 106 |
|
|
2022
Q3 | $618K | Sell |
2,739
-5
| -0.2% | -$1.21K | 0.03% | 104 |
|
|
2022
Q2 | $667K | Buy |
2,744
+3
| +0.1% | +$735 | 0.03% | 103 |
|
|
2022
Q1 | $662K | Buy |
2,741
+86
| +3% | +$19.8K | 0.03% | 106 |
|
|
2021
Q4 | $598K | Sell |
2,655
-113
| -4% | -$23.8K | 0.03% | 107 |
|
|
2021
Q3 | $588K | Buy |
2,768
+113
| +4% | +$26K | 0.03% | 106 |
|
|
2021
Q2 | $647K | Sell |
2,655
-1,605
| -38% | -$395K | 0.03% | 101 |
|
|
2021
Q1 | $1.06M | Sell |
4,260
-1,000
| -19% | -$239K | 0.05% | 95 |
|
|
2020
Q4 | $1.21M | Buy |
5,260
+960
| +22% | +$221K | 0.07% | 87 |
|
|
2020
Q3 | $1.09M | Sell |
4,300
-163
| -4% | -$40.4K | 0.07% | 89 |
|
|
2020
Q2 | $1.05M | Buy |
4,463
+28
| +0.6% | +$6.39K | 0.07% | 86 |
|
|
2020
Q1 | $899K | Sell |
4,435
-292
| -6% | -$63.8K | 0.07% | 90 |
|
|
2019
Q4 | $1.14M | Buy |
4,727
+1,107
| +31% | +$244K | 0.07% | 98 |
|
|
2019
Q3 | $701K | Sell |
3,620
-174
| -5% | -$33.4K | 0.05% | 105 |
|
|
2019
Q2 | $699K | Buy |
+3,794
| New | +$679K | 0.05% | 109 |
|
|
2017
Q2 | – | Sell |
-794
| Closed | -$130K | – | 145 |
|
|
2017
Q1 | $130K | Buy |
794
+95
| +14% | +$15.8K | 0.02% | 166 |
|
|
2016
Q4 | $102K | Sell |
699
-877
| -56% | -$132K | 0.01% | 155 |
|
|
2016
Q3 | $263K | Sell |
1,576
-456
| -22% | -$77.1K | 0.04% | 112 |
|
|
2016
Q2 | $309K | Sell |
2,032
-682
| -25% | -$106K | 0.05% | 96 |
|
|
2016
Q1 | $407K | Sell |
2,714
-73,446
| -96% | -$10.9M | 0.07% | 84 |
|
|
2015
Q4 | $12.4M | Buy |
76,160
+15,966
| +27% | +$2.51M | 2.13% | 17 |
|
|
2015
Q3 | $8.33M | Buy |
+60,194
| New | +$9.49M | 1.74% | 30 |
|
Other funds holding AMGN
Signature Estate & Investment Advisors's AMGN Position: Q2 2026 in Review
Signature Estate & Investment Advisors reduced its Amgen (AMGN) stake by 6.3% in Q2 2026, selling an estimated $143K and leaving 6,232 shares worth $2.26M. The position accounts for 0.04% of the portfolio, ranked #159.
Signature Estate & Investment Advisors first reported a position in AMGN in Q3 2015 and has held it in 36 quarters since. The position peaked at $12.4M in Q4 2015. 1,591 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Signature Estate & Investment Advisors held 6,232 shares of Amgen worth $2.26M as of Q2 2026.
- Signature Estate & Investment Advisors sold 418 Amgen shares in Q2 2026, an estimated $143K.
- Amgen made up 0.04% of Signature Estate & Investment Advisors's portfolio in Q2 2026, its #159 holding.
- Signature Estate & Investment Advisors first reported a position in Amgen in Q3 2015 and has held it in 36 quarters since.
- Signature Estate & Investment Advisors's Amgen position peaked at $12.4M in Q4 2015.
- 1,591 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.